Form 4: Rocket Pharmaceuticals Insider Sells Shares for Tax Withholding

Rocket Pharmaceuticals, Inc. reports that General Counsel Martin Wilson sold 3,361 shares of common stock to cover tax obligations related to vested Restricted Stock Units.

Summary

• Martin Wilson, General Counsel at Rocket Pharmaceuticals, Inc., sold 3,361 shares of common stock on May 13, 2026.
• The sale was conducted to cover tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Mr. Wilson beneficially owns 678,639 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing neutrally as it represents a standard transaction for tax purposes related to equity compensation, rather than a strategic decision about the company's performance.

Negatives

• Insider selling can sometimes be perceived negatively by the market, although in this case, it is for tax purposes related to RSU vesting.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to an insider stock transaction for tax purposes.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are a common and expected event, particularly when employees receive equity compensation like RSUs. This type of transaction is typically not indicative of a negative view on the company's future prospects.

Stakeholder Impact

• Shareholders: The sale is for tax purposes and does not necessarily reflect a change in the insider's long-term view of the company. The impact on share price is likely minimal.

Key Dates

Keywords

Rocket Pharmaceuticals, RCKT, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, RSUs, Beneficial Ownership